Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 7-(2-amino-2-(4-hydroxyphenyl)acetamido)-3-(propenyl)-3-cephem-4-carboxylic Acid Monohydrate
2. 7-(2-amino-2-(p-hydroxyphenyl)acetamido)-8-oxo-3-(1-propenyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
3. Arzimol
4. Bmy 28100
5. Bmy-28100
6. Brisoral
7. Cefprozil Monohydrate
8. Cefzil
9. Procef
1. Cefprozil Anhydrous
2. Cefzil
3. Cefprozilum
4. 92665-29-7
5. Cefprozilo
6. Brisoral
7. Cefprozilum [inn-latin]
8. Cefprozilo [inn-spanish]
9. Procef
10. Trans-cefprozil
11. 92676-86-3
12. Arzimol
13. S1sdi2fjiy
14. Cronocef
15. Serozil
16. Cefzil (tn)
17. Cefprozil Anhydrous, E-isomer
18. Bmy 28100
19. Cefprozil Hydrate (cefzil)
20. Cefprozil (e)-isomer (50 Mg)g0d341872ug/mg(ai)
21. (6s,7r)-7-((r)-2-amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-3-((e)-prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
22. Cefprozil (e)-isomer
23. Cefprozil (inn)
24. Cefprozil (tn)
25. Cefprozil [usan:inn]
26. Chebi:3506
27. Unii-1m698f4h4e
28. E-cefprozil
29. (e)-cefprozil
30. Bbs-1067
31. Bmy-28167
32. Unii-s1sdi2fjiy
33. Cefprozil [mart.]
34. Schembl37024
35. Bidd:gt0833
36. Cefprozil E-form [mi]
37. Chembl276568
38. Cefprozil For Peak Identification
39. Hy-b0458a
40. Dtxsid10873545
41. N,n-bisbenzylidenebenzidine
42. 1m698f4h4e
43. Hms3715p22
44. Cefprozil Anhydrous, (e)-
45. Zinc3776970
46. Akos015895989
47. Ccg-221280
48. Db01150
49. (6r,7r)-7-{[(2r)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
50. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2r)-amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-(1-propenyl)-, (6r,7r)-
51. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-(1-propenyl)-, (6r-(6alpha,7beta(r*)))-
52. As-14301
53. Discontinued. Please See C243933.
54. Cs-0013517
55. C06888
56. C16732
57. D07651
58. Ab01274812-01
59. Ab01274812_02
60. 665c297
61. Cefprozil, Mix Of Z (92%), And E (7%) Isomers
62. Q3231623
63. (6r,7r)-7-((r)-2-amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-3-((e)-prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
64. (6r,7r)-7-((r)-2-amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-3-((e)-prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
65. (6r,7r)-7-((r)-2-amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-3-((e)-prop-1-enyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
66. (6r,7r)-7-((r)-2-amino-2-(p-hydroxyphenyl)acetamido)-8-oxo-3-propenyl-5-thia-1-azabicyclo(4.2.0)oct-2(e)-ene-2-carboxylic Acid
67. (6r,7r)-7-[(2r)-2-amino-2-(4-hydroxyphenyl)acetamido]-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
68. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2r)-amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-(1e)-1-propenyl-,(6r,7r)-
Molecular Weight | 389.4 g/mol |
---|---|
Molecular Formula | C18H19N3O5S |
XLogP3 | -1.4 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 389.10454189 g/mol |
Monoisotopic Mass | 389.10454189 g/mol |
Topological Polar Surface Area | 158 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 699 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Cefprozil |
PubMed Health | Cefprozil (By mouth) |
Drug Classes | Antibiotic |
Drug Label | Cefprozil is a semi-synthetic broad-spectrum cephalosporin antibiotic.Cefprozil is a cis and trans isomeric mixture (90% cis). The chemical name for the monohydrate is (6R,7R)-7-[(R)-2-amino-2-(p-hydroxyphenyl)acetamido]-8-oxo-3-propenyl-5-thia-1-... |
Active Ingredient | Cefprozil |
Dosage Form | Tablet; For suspension |
Route | Oral |
Strength | 250mg; 125mg/5ml; 500mg; 250mg/5ml |
Market Status | Prescription |
Company | Wockhardt; Teva Pharms; Teva; Apotex; Aurobindo Pharma; Lupin; Sandoz; Orchid Hlthcare |
2 of 2 | |
---|---|
Drug Name | Cefprozil |
PubMed Health | Cefprozil (By mouth) |
Drug Classes | Antibiotic |
Drug Label | Cefprozil is a semi-synthetic broad-spectrum cephalosporin antibiotic.Cefprozil is a cis and trans isomeric mixture (90% cis). The chemical name for the monohydrate is (6R,7R)-7-[(R)-2-amino-2-(p-hydroxyphenyl)acetamido]-8-oxo-3-propenyl-5-thia-1-... |
Active Ingredient | Cefprozil |
Dosage Form | Tablet; For suspension |
Route | Oral |
Strength | 250mg; 125mg/5ml; 500mg; 250mg/5ml |
Market Status | Prescription |
Company | Wockhardt; Teva Pharms; Teva; Apotex; Aurobindo Pharma; Lupin; Sandoz; Orchid Hlthcare |
For the treatment of the following infections (respiratory, skin, soft tissue, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph
FDA Label
Cefprozil, a semisynthetic, second-generation cephalosporin, is used to treat otitis media, soft-tissue infections, and respiratory tract infections.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DC - Second-generation cephalosporins
J01DC10 - Cefprozil
Absorption
Oral bioavailability is approximately 95%.
Volume of Distribution
0.23 L/kg
Clearance
3 mL/min/kg [fasting subjects]
Cefprozil is eliminated primarily by the kidneys
1.3 hours
Cefprozil, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefprozil interferes with an autolysin inhibitor.
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17827
Submission : 2004-11-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17731
Submission : 2004-09-29
Status : Active
Type : II
Date of Issue : 2019-07-05
Valid Till : 2022-07-04
Written Confirmation Number : WC-0202
Address of the Firm :
NDC Package Code : 57297-400
Start Marketing Date : 2016-02-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17375
Submission : 2004-05-13
Status : Active
Type : II
Date of Issue : 2019-07-22
Valid Till : 2022-07-21
Written Confirmation Number : WC-0131
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24047
Submission : 2010-08-06
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-07-10
Pay. Date : 2012-12-19
DMF Number : 26699
Submission : 2013-01-09
Status : Active
Type : II
Certificate Number : R0-CEP 2020-252 - Rev 00
Issue Date : 2021-02-19
Type : Chemical
Substance Number : 2342
Status : Valid
Registrant Name : Kyungbo Pharmaceutical Co., Ltd.
Registration Date : 2022-03-17
Registration Number : 20180903-209-J-8(3)
Manufacturer Name : Qilu Antibiotics Pharmaceutical Co., Ltd.
Manufacturer Address : No.849 Dongjia Town, Licheng District, Jinan, Shandong Province, China
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21471
Submission : 2008-03-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18901
Submission : 2005-10-24
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17453
Submission : 2004-06-07
Status : Inactive
Type : II
Regulatory Info :
Registration Country : Italy
Brand Name : Cronocef
Dosage Form : Cefprozil 250Mg/5 Ml Oral Use
Dosage Strength : os suspe 250 mg 5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Cronocef
Dosage Form : Cefprozil 500Mg 6 Combined Oral Use
Dosage Strength : 6 CPR 500 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Turkey
Brand Name : Prefix
Dosage Form : Powder for Oral Suspension
Dosage Strength : 125MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name : Prefix
Dosage Form : Powder for Oral Suspension
Dosage Strength : 250MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name : Prefix
Dosage Form : Film Coated Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name : Prefix
Dosage Form : Film Coated Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Regulatory Info :
Registration Country : Italy
Brand Name : Prolizip
Dosage Form : Cefprozil 250Mg/5 Ml Oral Use
Dosage Strength : os suspe 60 ml 250 mg/5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Prolizip
Dosage Form : Cefprozil 500Mg 6 Combined Oral Use
Dosage Strength : 6 cpr riv 500 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Canada
CEFPROZIL (CEFPROZIL MONOHYDRATE)
Brand Name : AURO-CEFPROZIL
Dosage Form : POWDER FOR SUSPENSION
Dosage Strength : 125MG/5ML
Packaging :
Approval Date :
Application Number : 2347261
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : AURO-CEFPROZIL
Dosage Form : TABLET
Dosage Strength : 500MG
Packaging : 100
Approval Date :
Application Number : 2347253
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
CEFPROZIL (CEFPROZIL MONOHYDRATE)
Brand Name : AURO-CEFPROZIL
Dosage Form : POWDER FOR SUSPENSION
Dosage Strength : 250MG/5ML
Packaging :
Approval Date :
Application Number : 2347288
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
CEFPROZIL (CEFPROZIL MONOHYDRATE)
Brand Name : TARO-CEFPROZIL
Dosage Form : POWDER FOR SUSPENSION
Dosage Strength : 125MG/5ML
Packaging :
Approval Date :
Application Number : 2329204
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
CEFPROZIL (CEFPROZIL MONOHYDRATE)
Brand Name : TARO-CEFPROZIL
Dosage Form : POWDER FOR SUSPENSION
Dosage Strength : 250MG/5ML
Packaging :
Approval Date :
Application Number : 2293579
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
CEFPROZIL (CEFPROZIL MONOHYDRATE)
Brand Name : TARO-CEFPROZIL
Dosage Form : TABLET
Dosage Strength : 250MG
Packaging : 100
Approval Date :
Application Number : 2293528
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
CEFPROZIL (CEFPROZIL MONOHYDRATE)
Brand Name : TARO-CEFPROZIL
Dosage Form : TABLET
Dosage Strength : 500MG
Packaging : 100
Approval Date :
Application Number : 2293536
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Italy
Brand Name :
Dosage Form : Capsules
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Packaging :
Regulatory Info :
Dosage : Capsules
Dosage Strength : 250MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name :
Dosage Form : Capsules
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Packaging :
Regulatory Info :
Dosage : Capsules
Dosage Strength : 500MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name :
Dosage Form : Suspensions
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Packaging :
Regulatory Info :
Dosage : Suspensions
Dosage Strength : 250MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Italy
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Oral Suspension
Dosage Strength : 250MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Oral Suspension
Dosage Strength : 250MG/5ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 250MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 500MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : Tablet
Dosage Strength : 250MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : Tablet
Dosage Strength : 500MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic EU CTD
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic EU CTD
Registration Country : India
Packaging :
Regulatory Info : Generic EU CTD
Dosage : TABLET
Dosage Strength : 250MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic EU CTD
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic EU CTD
Registration Country : India
Packaging :
Regulatory Info : Generic EU CTD
Dosage : TABLET
Dosage Strength : 500MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Cefprozil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefprozil, including repackagers and relabelers. The FDA regulates Cefprozil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefprozil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cefprozil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cefprozil supplier is an individual or a company that provides Cefprozil active pharmaceutical ingredient (API) or Cefprozil finished formulations upon request. The Cefprozil suppliers may include Cefprozil API manufacturers, exporters, distributors and traders.
click here to find a list of Cefprozil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cefprozil DMF (Drug Master File) is a document detailing the whole manufacturing process of Cefprozil active pharmaceutical ingredient (API) in detail. Different forms of Cefprozil DMFs exist exist since differing nations have different regulations, such as Cefprozil USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cefprozil DMF submitted to regulatory agencies in the US is known as a USDMF. Cefprozil USDMF includes data on Cefprozil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cefprozil USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cefprozil suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cefprozil Drug Master File in Korea (Cefprozil KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cefprozil. The MFDS reviews the Cefprozil KDMF as part of the drug registration process and uses the information provided in the Cefprozil KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cefprozil KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cefprozil API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cefprozil suppliers with KDMF on PharmaCompass.
A Cefprozil CEP of the European Pharmacopoeia monograph is often referred to as a Cefprozil Certificate of Suitability (COS). The purpose of a Cefprozil CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cefprozil EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cefprozil to their clients by showing that a Cefprozil CEP has been issued for it. The manufacturer submits a Cefprozil CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cefprozil CEP holder for the record. Additionally, the data presented in the Cefprozil CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cefprozil DMF.
A Cefprozil CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cefprozil CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cefprozil suppliers with CEP (COS) on PharmaCompass.
A Cefprozil written confirmation (Cefprozil WC) is an official document issued by a regulatory agency to a Cefprozil manufacturer, verifying that the manufacturing facility of a Cefprozil active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cefprozil APIs or Cefprozil finished pharmaceutical products to another nation, regulatory agencies frequently require a Cefprozil WC (written confirmation) as part of the regulatory process.
click here to find a list of Cefprozil suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cefprozil as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cefprozil API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cefprozil as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cefprozil and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cefprozil NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cefprozil suppliers with NDC on PharmaCompass.
Cefprozil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefprozil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cefprozil GMP manufacturer or Cefprozil GMP API supplier for your needs.
A Cefprozil CoA (Certificate of Analysis) is a formal document that attests to Cefprozil's compliance with Cefprozil specifications and serves as a tool for batch-level quality control.
Cefprozil CoA mostly includes findings from lab analyses of a specific batch. For each Cefprozil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefprozil may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefprozil EP), Cefprozil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefprozil USP).
LOOKING FOR A SUPPLIER?